We are live on
!
Find out more
WINT
Windtree Therapeutics
WINT
WINT
Delisted
WINT was delisted on the 20th of August, 2025.
4 hedge funds and large institutions have $390K invested in Windtree Therapeutics in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
7,908% more capital invested
Capital invested by funds: $4.87K → $390K (+$385K)
300% more funds holding
Funds holding: 1 → 4 (+3)
0.2% more ownership
Funds ownership: 0.01% → 0.2% (+0.2%)
Holders
4
Holders Change
+3
Holders Change %
+300%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
AC
Armistice Capital
New York
|
+$948K |
| 2 |
Morgan Stanley
New York
|
+$22.4K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.72K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$2.42K |
Top Sellers
No sellers this quarter